| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Vaccination with selected synovial T cells in rheumatoid arthritis. | Arthritis Rheum | 2007 | 1.53 |
| 2 | Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. | J Clin Invest | 2005 | 1.42 |
| 3 | Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. | J Rheumatol | 2005 | 0.90 |
| 4 | A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. | Rheumatol Int | 2008 | 0.84 |
| 5 | Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. | Chin Med J (Engl) | 2003 | 0.78 |
| 6 | [Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs]. | Zhonghua Liu Xing Bing Xue Za Zhi | 2002 | 0.76 |